A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer

Metastatic castration resistant prostate cancer (mCRPC) is one of the most common cancers with a poor prognosis. To improve prognostic models of mCRPC, the Dialogue for Reverse Engineering Assessments and Methods (DREAM) Consortium organized a crowdsourced competition known as the Prostate Cancer DR...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoudian, Mehrad, Seyednasrollah, Fatemeh, Koivu, Liisa, Hirvonen, Outi, Jyrkkiö, Sirkku, Elo, Laura L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Method Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556990/
https://www.ncbi.nlm.nih.gov/pubmed/31231503
http://dx.doi.org/10.12688/f1000research.8192.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556990/
https://www.ncbi.nlm.nih.gov/pubmed/31231503
http://dx.doi.org/10.12688/f1000research.8192.2

Ejemplares similares